Callan Family Office’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.2M Sell
35,227
-2,200
-6% -$1.11M 0.37% 48
2025
Q4
$21.2M Buy
37,427
+6,920
+23% +$3.68M 0.46% 37
2025
Q3
$13.6M Sell
30,507
-1,796
-6% -$862K 0.43% 43
2025
Q2
$17.6M Buy
32,303
+18,134
+128% +$9.48M 0.55% 29
2025
Q1
$7.02M Sell
14,169
-282
-2% -$156K 0.53% 34
2024
Q4
$7.54M Buy
+14,451
New +$7.53M 0.48% 38

Other funds holding ISRG

Callan Family Office's ISRG Position: Q1 2026 in Review

Callan Family Office reduced its Intuitive Surgical (ISRG) stake by 5.9% in Q1 2026, selling an estimated $1.11M and leaving 35,227 shares worth $16.2M. The position accounts for 0.37% of the portfolio, ranked #48.

Callan Family Office first reported a position in ISRG in Q4 2024 and has held it in 6 quarters since. The position peaked at $21.2M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Callan Family Office held 35,227 shares of Intuitive Surgical worth $16.2M as of Q1 2026.
  • Callan Family Office sold 2,200 Intuitive Surgical shares in Q1 2026, an estimated $1.11M.
  • Intuitive Surgical made up 0.37% of Callan Family Office's portfolio in Q1 2026, its #48 holding.
  • Callan Family Office first reported a position in Intuitive Surgical in Q4 2024 and has held it in 6 quarters since.
  • Callan Family Office's Intuitive Surgical position peaked at $21.2M in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.